Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-19
2009-12-01
Desai, Rita J (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S500000
Reexamination Certificate
active
07625886
ABSTRACT:
The present invention relates to the CGRP antagonists of general formula Iwherein R1, R2, R3and R4are defined as in claim1, the tautomers, the isomers, the diastereomers, the enantiomers, the hydrates thereof, the mixtures thereof and the salts thereof and the hydrates of the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, as well as those compounds of general formula I wherein one or more hydrogen atoms are replaced by deuterium, pharmaceutical compositions containing these compounds, their use and processes for preparing them.
REFERENCES:
patent: 6344449 (2002-02-01), Rudolf et al.
patent: 6521609 (2003-02-01), Doods et al.
patent: 7479488 (2009-01-01), Mueller et al.
patent: 7491717 (2009-02-01), Mueller et al.
patent: 7439237 (2009-04-01), Rudolf et al.
patent: 2004/0192729 (2004-09-01), Rudolf et al.
patent: 2005/0227968 (2005-10-01), Lustenberger et al.
patent: 2006/0079504 (2006-04-01), Rudolf et al.
patent: 2006/0252931 (2006-11-01), Mueller et al.
patent: 2007/0244099 (2007-10-01), Rudolf et al.
patent: 2503455 (2004-05-01), None
patent: 2503462 (2004-05-01), None
patent: 2558889 (2005-10-01), None
patent: 2562526 (2005-10-01), None
patent: 2565219 (2005-11-01), None
patent: WO 01/32649 (2001-05-01), None
patent: 2004037810 (2004-05-01), None
patent: 2004037811 (2004-05-01), None
patent: 2004063171 (2004-07-01), None
patent: 2005084672 (2005-09-01), None
patent: 2005092880 (2005-10-01), None
patent: 2005100343 (2005-10-01), None
patent: 2005103037 (2005-11-01), None
patent: 2006100009 (2006-09-01), None
Silverman, R.B. The Organic Chemistry of Drug Design and Drug Action 1992, Academic: New York, p. 19.
Mueller et al.; Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions; U.S. Appl. No. 12/246,067, filed Oct. 6, 2008.
Mueller et al.; New CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions; U.S. Appl. No. 12/363,175, filed on Jan. 30, 2009.
Mueller et al.; Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions; U.S. Appl. No. 12/186,005, filed Aug. 5, 2008.
Arndt Kirsten
Doods Henri
Lustenberger Philipp
Mueller Stephan Georg
Rudolf Klaus
Boehringer Ingelheim International GmbH
Desai Rita J
Devlin Mary-Ellen M.
Morris Michael P.
O'Dell David K
LandOfFree
Selected CGRP antagonists, processes for preparing them and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selected CGRP antagonists, processes for preparing them and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selected CGRP antagonists, processes for preparing them and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4113470